Top Markets
#1 Official Trump Official Trump +44.68%
#2 Melania Meme Melania Meme +22.66%
#3 EXOD EXOD +22.08%
#4 Movement Movement +19.54%
#5 Mubarak Mubarak +18.92%
#6 Wrapped POL Wrapped POL +18.17%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.83%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +17.59%
#9 Unit Pump Unit Pump +11.33%
#10 Pump.fun Pump.fun +11.33%
Coin of the day
Official Trump Official Trump
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Shree Ganesh Remedies Limited Shree Ganesh Remedies Limited

Shree Ganesh Remedies Limited

SGRL
Clasificación en acciones #23577
Shree Ganesh Remedies Ltd. operates within the healthcare industry,... Shree Ganesh Remedies Ltd. operates within the healthcare industry, specializing in the entire process of conceiving, developing, producing, and distributing medical goods. Their portfolio features a variety of items such as pharmaceutical intermediates, finished drugs, animal health products, and active pharmaceutical ingredients (APIs). The company, which was established on April 27, 1995, has its corporate headquarters in Ankleshwar, India.
Precio por acción
$5.59
Última sincronización: 2026-08-21
Capitalización bursátil
$71.74M
Cambio (1 día)
0.95%
Cambio (1 año)
-17.66%
País
IN
Comercio Shree Ganesh Remedies Limited (SGRL)

Categoría

Healthcare
Ganancias de Shree Ganesh Remedies Limited (SGRL)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Shree Ganesh Remedies Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Shree Ganesh Remedies Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT